ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer

In patients with metastatic colon cancer, response to first line chemotherapy is a strong predictor of overall survival (OS). Currently, oncologists lack diagnostic tests to determine which chemotherapy regimen offers the greatest chance for response in an individual patient. Here we present the res...

Descripción completa

Detalles Bibliográficos
Autores principales: Choueiri, Michel B., Shen, John Paul, Gross, Andrew M., Huang, Justin K., Ideker, Trey, Fanta, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470586/
https://www.ncbi.nlm.nih.gov/pubmed/26083491
http://dx.doi.org/10.1371/journal.pone.0126898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470586/
https://www.ncbi.nlm.nih.gov/pubmed/26083491
http://dx.doi.org/10.1371/journal.pone.0126898

Ejemplares similares